Vioxx Recalled Due to Cardiovascular Side Effects
Last Updated on June 26, 2017
Investigation Complete
Attorneys working with ClassAction.org have finished their investigation into this matter.
Check back for any potential updates and take a look at our open investigations here. The information on this page is for reference only.
At A Glance
- This Alert Affects
- Individuals who suffered a heart attack or stroke while taking prescribed Vioxx may be eligible to participate in litigation and recover compensation.
- Damages
- Vioxx has been linked to serious, life threatening side effects, such as heart attack and stroke. Other reported side effects include intestinal bleeding, blood clots, and kidney problems.
- Company(ies)
- Merck & Co.
- Additional Details
- Vioxx is a prescription COX-2 selective, non-steroidal anti-inflammatory drug. It was introduced in 1999 for the management of acute pain in adults. It was later approved for the treatment of rheumatoid arthritis in adults and children.
- Date
- Vioxx was recalled by Merck & Co. on September 30, 2004.
Vioxx (Rofecoxib) is a prescription nonsteroidal anti-inflammatory drug. It is manufactured by Merck & Co. and was approved by the Food and Drug Administration in 1999. It is intended to treat osteoarthritis, menstrual cramps, rheumatoid arthritis, and other causes of acute pain. However, serious concerns have been raised over the safety of this drug, particularly the increased risk of heart attack, stroke, and other serious cardiovascular events. On September 30, 2004, Vioxx was recalled by Merck & Co. after a medical study found that patients taking the drug had a higher rate of heart attacks and strokes than those on a placebo. If you have suffered serious medical side effects after taking Vioxx, you may be eligible to participate in a lawsuit. Victims of heart attack and stroke may be able to recover compensation for the damages they have suffered.
Before commenting, please review our comment policy.